Q'Apel Medical
PrivateLast Round
VC Round
May 9, 2024
Est. Valuation
$120.95M
Total Funding Raised
$67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Q'Apel Medical operates in Healthcare & Life Sciences and is based in Fremont, California. Its latest recorded funding round was a VC Round in May 2024.
Q'Apel Medical is a medical devices company that develops and commercializes novel access device technology for neurovascular interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Q'Apel Medical Comparables
Compare Q'Apel Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MIVI Neuroscience | 90% | |
| Route 92 Medical | 89% | |
| Rapid Medical | 89% |
For institutional investors. Book with your work email.
Q'Apel Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 9, 2024 | ||||
| Series D | May 11, 2022 | ||||
| Series C | Feb 11, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Q'Apel Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series D, Series C |
| Research Corporation Technologies | Series C, Series D |
| Cormorant Asset Management | Series D |
| RC Capital | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 67% MoM, reaching 5.2K.
- Jun 20, 2026
Monthly visitors increased 83% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 9, 2026
Q'Apel Medical Inc. launches the Lynx(TM) Aspiration Catheter System in the United States on Sep 9th '26 in California to support physicians performing mechanical thrombectomy for acute ischemic stroke caused by vessel occlusion.
For institutional investors. Book with your work email.
Q'Apel Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Q'Apel Medical's valuation, stock price, and market status.
Is Q'Apel Medical a public or private company?
Q'Apel Medical is a private company.
What is the current stock price of Q'Apel Medical?
Q'Apel Medical is a private company, so its shares have no public market price. Caplight tracks Q'Apel Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Q'Apel Medical worth (valuation)?
Q'Apel Medical's valuation is estimated at $121.0M based on funding round data.
Can I buy Q'Apel Medical stock?
Q'Apel Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Q'Apel Medical's last funding round?
Q'Apel Medical's most recent funding round was VC Round on May 9, 2024.
Who are the main investors in Q'Apel Medical?
Key investors in Q'Apel Medical include Soleus Capital, Cormorant Asset Management, RC Capital.
Will Q'Apel Medical IPO soon?
No public IPO plans have been announced for Q'Apel Medical.
How can I track Q'Apel Medical secondary market activity?
Caplight tracks bids, offers, and trades in Q'Apel Medical's shares on secondary markets.